The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry

被引:61
作者
Jiang, N
Aittomäki, K
Nilsson, C
Pakarinen, P
Iitiä, A
Torresani, T
Simonsen, K
Goh, V
Pettersson, K
de la Chapelle, A
Huhtaniemi, I
机构
[1] Univ Turku, Dept Physiol, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Biotechnol, FIN-20520 Turku, Finland
[3] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki 00029, Finland
[4] Folkhalsan Inst Genet, Helsinki 00280, Finland
[5] Univ Zurich, Childrens Hosp, Div Endocrinol, CH-8032 Zurich, Switzerland
[6] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark
[7] Natl Univ Singapore, Dept Obstet & Gynecol, Singapore 119074, Singapore
[8] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1210/jc.83.12.4338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have described previously in the Finnish population an inactivating point mutation (C-566-->T) in the human FSH receptor (FSHR) gene. In women, this mutation causes hypergonadotropic ovarian failure with arrest of follicular maturation and infertility, whereas in men, there is variable suppression of spermatogenesis, but no absolute infertility. To determine whether the same FSHR mutation occurs in other populations, its frequency was determined in Finland, Switzerland, Denmark, and the Chinese population of Singapore. The mutation was screened for using genomic DNA extracted from whale blood or dried blood spots. Exon 7 of the FSHR gene was first amplified using a pair of biotinylated primers. The PCR products were then immobilized on streptavidin-coated microtitration wells and hybridized using short allele-specific oligonucleotide probes labeled with europium. Time-resolved fluorometry was used for europium signal detection. To test the reliability of this method, 40 isolated DNA samples and 35 dried blood spot samples were blindly tested for the C-566-->T FSHR mutation. The analyses yielded identical results with denaturing gradient gel electrophoresis and allele-specific restriction enzyme digestion of the same samples, thus demonstrating the reliability of the tested method. Automation of this procedure allows the screening of large numbers of samples, which was subsequently carried out to investigate the frequency of the C-566-->T mutation in the study populations. A total of 4981 samples from the above-mentioned 4 countries were analyzed. The frequency of the C-566-->T mutation was 0.96% for all Finnish samples (n = 1976), with a strong enrichment of the mutant allele in the northeastern part of the country. Only 1 mutation carrier was identified in the samples from Switzerland (n = 1162), whereas none was found in samples from Denmark (n = 1094) and the Singapore Chinese (n = 540). These results suggest that the C-566-->T mutation of the FSHR gene is enriched in Finland, but is uncommon in other populations.
引用
收藏
页码:4338 / 4343
页数:6
相关论文
共 37 条
  • [1] AITTOMAKI K, 1994, AM J HUM GENET, V54, P844
  • [2] Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene
    Aittomaki, K
    Herva, R
    Stenman, UH
    Juntunen, K
    Ylostalo, P
    Hovatta, O
    delaChapelle, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3722 - 3726
  • [3] MUTATION IN THE FOLLICLE-STIMULATING-HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE
    AITTOMAKI, K
    LUCENA, JLD
    PAKARINEN, P
    SISTONEN, P
    TAPANAINEN, J
    GROMOLL, J
    KASKIKARI, R
    SANKILA, EM
    LEHVASLAIHO, H
    ENGEL, AR
    NIESCHLAG, E
    HUHTANIEMI, I
    DELACHAPELLE, A
    [J]. CELL, 1995, 82 (06) : 959 - 968
  • [4] REFINED LOCALIZATION OF THE GENE CAUSING X-LINKED JUVENILE RETINOSCHISIS
    ALITALO, T
    KRUSE, TA
    DELACHAPELLE, A
    [J]. GENOMICS, 1991, 9 (03) : 505 - 510
  • [5] Gonadotrophin receptors
    Clayton, RN
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1996, 10 (01): : 1 - 8
  • [6] Clinical manifestations of genetic defects affecting gonadotrophins and their receptors
    Conway, GS
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (06) : 657 - 663
  • [7] DAHLEN P, 1993, CLIN CHEM, V39, P1626
  • [8] DAHLEN PO, 1991, J CLIN MICROBIOL, V29, P798
  • [9] DISEASE GENE-MAPPING IN ISOLATED HUMAN-POPULATIONS - THE EXAMPLE OF FINLAND
    DELACHAPELLE, A
    [J]. JOURNAL OF MEDICAL GENETICS, 1993, 30 (10) : 857 - 865
  • [10] DERMER SJ, 1988, LAB INVEST, V59, P403